Cubist Systematic Strategies, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,780
-96.6%
34,802
-92.4%
0.00%
-92.9%
Q2 2023$2,165,500
-40.9%
454,937
-29.3%
0.01%
-36.4%
Q1 2023$3,665,778
-36.5%
643,119
+12.3%
0.02%
-35.3%
Q4 2022$5,777,019
-0.3%
572,549
+121.4%
0.03%
+3.0%
Q3 2022$5,796,000
-36.3%
258,626
-29.5%
0.03%
-41.1%
Q2 2022$9,096,000
+1280.3%
367,062
+2058.4%
0.06%
+833.3%
Q1 2022$659,000
+6.3%
17,006
+60.5%
0.01%0.0%
Q4 2021$620,000
-87.1%
10,596
-86.9%
0.01%
-90.2%
Q3 2021$4,803,000
+194.5%
81,034
+331.1%
0.06%
+238.9%
Q2 2021$1,631,000
-54.1%
18,796
-56.4%
0.02%
-60.0%
Q1 2021$3,552,000
-45.3%
43,079
-39.6%
0.04%
-49.4%
Q4 2020$6,489,000
+87.8%
71,360
-17.5%
0.09%
+74.5%
Q3 2020$3,456,000
+115100.0%
86,472
+86372.0%
0.05%
Q2 2020$3,000
-99.7%
100
-99.8%
0.00%
-100.0%
Q4 2019$865,00044,217
+884240.0%
0.02%
Q3 2019$0
-100.0%
5
-99.9%
0.00%
-100.0%
Q2 2019$100,000
+100.0%
4,948
+72.9%
0.00%0.0%
Q1 2019$50,000
-81.7%
2,862
-86.5%
0.00%
-84.6%
Q4 2018$273,00021,2650.01%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders